Renal Osteodystrophy Market Outlook 2029: Presents Market Insights & Depth Analysis
The global renal osteodystrophy market is anticipated to grow at a favourable CAGR during the forecast period. The major factors that enhances the market growth include increasing habit of tobacco & alcohol consumption causing higher chances of kidney related problem and increasing population pool with diabetes and high blood pressure patients. Moreover, according to cancer.org, alcohol use is one of the most important preventable risk factors for cancer, along with tobacco use and excess body weight. Alcohol use accounts for about 6% of all cancers and 4% of all cancer deaths in the US in June 2020. Owing to rising consumtopn of alcohol and smoking, among all age group enhances the market growth.
Similalry, in 2019, 37.3 million Americans, or 11.3% of the
population, had diabetes. Nearly 1.9 million Americans have type 1 diabetes,
including about 244,000 children and adolescents, and in 2019, diabetes was
mentioned as a cause of death in a total of 282,801 certificates in the US,
according to the American Diabetes Association. Hence rising prevalence of
diabetes, among all age group results in sudden kidney failure, which in turn
fueled the growth of the global renal osteodystrophy market.
To Request a Sample of our Report on Renal Osteodystrophy
Market: https://www.omrglobal.com/request-sample/renal-osteodystrophy-market
Market Coverage
• The
market number available for – 2022-2030
• Base
year- 2022
• Forecast
period- 2023-2030
• Segment
Covered- by diagnosis method, by treatment
• Regions
Covered- North America, Europe, Asia-Pacific, Rest of the World
• Competitive
Landscape- are are Amgen Inc., Asahi Kasei Corp., and B. Braun Medical, Baxter
International Inc., DaVita Inc., and others
Renal Osteodystrophy Market– Segmentation
By Diagnosis Method
·
Bone Biopsy
·
Blood Test
By Treatment
·
Hemodialysis
·
Kidney Transplantation
·
Medication (Cinacalcet, Rocaltrol)
·
Parathyroidectomy
A
full Report of Renal Osteodystrophy
Market is Available @ https://www.omrglobal.com/industry-reports/renal-osteodystrophy-market
Renal Osteodystrophy Market by Region
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
•
Latin America
•
Middle East and Africa
Company
Profiles
·
Abbott Laboratories Inc.
·
AbbVie Inc.
·
Amgen Inc.
·
Asahi Kasei Corp.
·
B. Braun Medical
·
Baxter International Inc.
·
DaVita Inc.
·
Fresenius Medical Care Holdings, Inc
·
Nikkiso Co., Ltd.
·
Nipro Corp.
·
Rockwell Medical Inc.
·
Teleflex Inc.
·
Toray Industries, Inc.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/renal-osteodystrophy-market
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services. The
company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment